An interventional study of Family Walking Instruction with Support by Heart (Family WISH) program and Comparison group in Heart Defects, Congenital, sponsored by Chi-Wen Chen. Not yet recruiting at 1 site in Taiwan. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-12.
Sponsored by Chi-Wen Chen · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Heart Defects, Congenital with a site in Taiwan — 3 open to participants now, 5 under way, none of them phase 3. Heart Defects, Congenital · Taiwan.
Among the 13 studies in Heart Defects, Congenital with a site in Taiwan, this one is the 7th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 7 with no phase, and was the 10th registered.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
Browse Heart Defects, Congenital studies →3 of the 13 studies in Heart Defects, Congenital with a site in Taiwan are open now. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Fu Jen Catholic University · Sites in Taiwan
Ages 6 mo+
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.
This study: 12 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 104 is above the median of 60 across 508 interventional studies indexed under Heart Defects, Congenital.
Median enrollment 120 across the 10 interventional studies, 4,000 across the 3 observational. Of the 8 that completed or were terminated, 3 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 13 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Chi-Wen Chen as lead sponsor.
Chi-Wen Chen has 1 study filed under Heart Defects, Congenital — fewer than ten, so there is no comparison to draw.
4 of the studies in Heart Defects, Congenital with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06763497National Taiwan University HospitalThe Efficacy of Systematic Oral Feeding Education Program | 2026-12-19 |
| NCT06872320Chang Gung Memorial HospitalThe Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease | 2026-12-31 |
| NCT07937579Fu Jen Catholic UniversityEfficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures | 2027-07-31 |
| NCT06719323Chi-Wen ChenLong-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease | 2027-07-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 13 studies in Heart Defects, Congenital with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn the long-term effects of "Family Walking Instruction with Support by Heart" (Family WISH) on frailty state, quality of life and family functioning among adolescents with congenital heart disease (CHD).
Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Experimental group: a 12-week Family WISH program
Comparison group: a family walking health education sheet received
Behavioral: Comparison group
Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.
a family walking health education sheet received
frailty state
self-reported questionnaire completed
Time frame: at baseline, and at 6, 12, and 24 weeks
quality of life and family functioning
self-reported questionnaires completed
Time frame: at baseline, and at 6, 12, and 24 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Jul 2027, 13 months later.
Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 13 months is below that.
Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.